8-KEarnings & ResultsExhibits & Filings

BIOGEN INC. 8-K Report, Financial Results (Apr 20, 2010)

Filed April 20, 2010For Securities:BIIB

Summary

Biogen Idec Inc. filed a Form 8-K on April 20, 2010, to announce its financial results for the first quarter ended March 31, 2010. The report primarily incorporates by reference a press release issued by the company on the same date, which contains details on the company's operational performance and financial condition for the period. Investors should refer to the furnished press release (Exhibit 99) for specific financial figures, including revenue, earnings, and any forward-looking statements or business updates. The filing itself does not contain detailed financial tables but directs investors to the attached press release for comprehensive information. This report serves as the official notification of Biogen Idec's Q1 2010 financial performance. While the 8-K itself is a brief procedural filing, the accompanying press release is crucial for understanding the company's recent financial health, operational highlights, and potential outlook. Investors are advised to review Exhibit 99 for detailed insights into revenue drivers, expense management, profitability, and any significant developments that could impact the company's stock value.

Key Highlights

  • 1Biogen Idec announced its Q1 2010 financial and operational results via a press release filed on April 20, 2010.
  • 2The primary information for investors is contained within the furnished press release (Exhibit 99).
  • 3The 8-K filing itself is procedural and serves to incorporate the press release.
  • 4Investors should consult Exhibit 99 for specific financial data, performance metrics, and business updates.
  • 5The filing does not contain detailed financial statements directly within the 8-K form.
  • 6This report signifies the official disclosure of Biogen Idec's performance for the three months ended March 31, 2010.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce Biogen Idec's financial results and operational performance for the first quarter ended March 31, 2010, by furnishing a press release containing these details.

The detailed financial results, including revenue, earnings, and other performance metrics for the quarter ended March 31, 2010, are provided in the press release issued by Biogen Idec on April 20, 2010, which is included as Exhibit 99 to this 8-K filing.

No, the press release furnished pursuant to Item 2.02 is generally not deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, nor is it subject to the liabilities of that section, unless specifically incorporated into other SEC filings.

Investors should look for key financial figures such as quarterly revenue, net income, earnings per share (EPS), as well as any commentary on product sales, pipeline updates, and forward-looking guidance provided by the company in the press release (Exhibit 99).